ArticleClinical and experimental nephrology2019

Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients.

Chunyu Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.